Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ORM2 encodes a key acute phase plasma protein. Additionally we are shipping Orosomucoid 2 Kits (21) and Orosomucoid 2 Proteins (13) and many more products for this protein.
Showing 10 out of 72 products:
data support the consideration that alpha-1 acid glycoprotein (show ORM1 Antibodies) is a negative acute-phase reactant and appears to be regulated by cytokines
Data suggest that AGP/ORM1 (show ORM1 Antibodies) level in blood at birth is reflective of growth conditions in utero or fetal maturation and may serve as an early predictive biomarker for pre-weaning growth rate.
Data indicate decreases in serum alpha-1 acid glycoprotein (show ORM1 Antibodies) concentration and in hepatic ORM1 (show ORM1 Antibodies) expression during the acute phase response.
expression of ORM1 (show ORM1 Antibodies) mRNA in liver, adipose tissue well as the serum concentration of ORM (show ORM1 Antibodies) protein in three porcine obesity models; the domestic pig, Gottingen minipigs and Ossabaw minipigs
This study suggested closer links between the release of haptoglobin (show HP Antibodies), Pig-MAP and monocytes compared to the release of AGP, SAA (show SAA1 Antibodies) and transthyretin (show TTR Antibodies).
the glycosylation change of alpha-1-acid glycoprotein (AGP (show ORM1 Antibodies)) in hepatocellular carcinoma (HCC (show FAM126A Antibodies)), cirrhosis and controls
Neural cell interactions are important for brain physiology and pathology. Particularly, the interaction between non-neuronal cells plays a central role in regulating brain inflammation, which is closely linked to many brain disorders. Here, we newly identified orosomucoid-2 (ORM2) as an endogenous protein that mediates such non-neuronal glial cell interactions
Low ORM2 expression is associated with metastasis in hepatocellular carcinoma.
Data suggest that human serum albumin (HSA) might serve as a carrier in delivering chitooligomers to target tissues than alpha-1-glycoprotein (AGP) which has pharmacological importance.
Identify ORM (show ATP5A1 Antibodies) genetic variations/haplotype structure associated with serum alpha-1-acid glycoprotein (show ORM1 Antibodies) level and the pharmacokinetics of paclitaxel in Japanese cancer patients.
Data indicate that the band intensity of sialic acid content in alpha-1 Acid glycoprotein (AGP (show ORM1 Antibodies)) of alcoholic liver cirrhosis was found to be lower than that in pooled control group.
These findings suggest that the ORM (show ATP5A1 Antibodies) distal promoter region differentially regulates expression of ORM (show ATP5A1 Antibodies) genes at basal level and in acute phase responses.
Alteration in expression of ORM2 suggests that ORM2 could be used as a potential biomarker in the diagnosis of colorectal cancer.
Characterized are more than 150 human Alpha-1-acid glycoprotein (show ORM1 Antibodies) isoforms, differing both in the amino acid sequence and in the glycosylation.
The binding of coumarin enantiomers to ORM2 is studied.
This gene encodes a key acute phase plasma protein. Because of its increase due to acute inflammation, this protein is classified as an acute-phase reactant. The specific function of this protein has not yet been determined\; however, it may be involved in aspects of immunosuppression.
alpha-1 acid glycoprotein
, AGP 2
, OMD 2
, alpha-1-acid glycoprotein 2
, alpha-1-acid glycoprotein, type 2
, alpha-1-acid glycoprotein 1
, bM340H1.5 (orosomucoid 2)